Bing Han

3.1k total citations
95 papers, 2.2k citations indexed

About

Bing Han is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Bing Han has authored 95 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 28 papers in Oncology and 28 papers in Cancer Research. Recurrent topics in Bing Han's work include Cancer-related molecular mechanisms research (14 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (8 papers). Bing Han is often cited by papers focused on Cancer-related molecular mechanisms research (14 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (8 papers). Bing Han collaborates with scholars based in China, United States and Canada. Bing Han's co-authors include Patrick Suppes, Zhong‐Lin Lu, Mingyao Liu, Shaf Keshavjee, Liqun Wu, Yunliang Wang, Honglei Yin, Likun Zhuang, Marco Mura and Thomas K. Waddell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Bing Han

88 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Han China 25 1.1k 731 340 302 300 95 2.2k
Jun Hu China 26 818 0.8× 554 0.8× 434 1.3× 232 0.8× 245 0.8× 87 1.9k
Wen‐Chin Huang United States 33 1.7k 1.5× 1.0k 1.4× 622 1.8× 511 1.7× 288 1.0× 86 3.4k
Wenwei Zhu China 21 863 0.8× 580 0.8× 398 1.2× 364 1.2× 148 0.5× 67 1.9k
Yanfeng Liu China 30 1.4k 1.3× 667 0.9× 469 1.4× 260 0.9× 194 0.6× 122 2.6k
Peng Wei United States 30 1.5k 1.4× 405 0.6× 257 0.8× 159 0.5× 254 0.8× 178 3.2k
Lisheng Zhang China 30 1.1k 1.0× 340 0.5× 360 1.1× 141 0.5× 313 1.0× 78 2.1k
Hui Yan China 28 970 0.9× 413 0.6× 336 1.0× 263 0.9× 183 0.6× 129 2.4k
Liu Liu China 30 1.7k 1.5× 543 0.7× 403 1.2× 433 1.4× 165 0.6× 159 3.1k
Xuguang Yang China 24 731 0.7× 434 0.6× 855 2.5× 178 0.6× 251 0.8× 51 2.4k
Jeong‐Ah Kim South Korea 34 545 0.5× 470 0.6× 303 0.9× 332 1.1× 339 1.1× 208 3.8k

Countries citing papers authored by Bing Han

Since Specialization
Citations

This map shows the geographic impact of Bing Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Han more than expected).

Fields of papers citing papers by Bing Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Han. The network helps show where Bing Han may publish in the future.

Co-authorship network of co-authors of Bing Han

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Han. A scholar is included among the top collaborators of Bing Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Han. Bing Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qi, et al.. (2025). Histone modification inhibitors: An emerging frontier in thyroid Cancer therapy. Cellular Signalling. 131. 111703–111703. 1 indexed citations
2.
Han, Bing, Mengyu Chen, Di Mu, et al.. (2025). USP14 and UCHL5 synergistically deubiquitinate PKCα and translocate NF-κB to promote the progression of anaplastic thyroid cancer. Cell Death and Disease. 16(1). 617–617.
3.
Zhang, Jingjing, Xiaowei Chen, Bing Han, et al.. (2025). Electronic Structure Modulation of Nb 2 O 5 by Ru Single Atoms Enabling Efficient Hydrogen Storage of Magnesium Hydrides. Angewandte Chemie International Edition. 64(33). e202511139–e202511139. 6 indexed citations
4.
Zhang, Jingjing, Xiaowei Chen, Bing Han, et al.. (2025). Electronic Structure Modulation of Nb 2 O 5 by Ru Single Atoms Enabling Efficient Hydrogen Storage of Magnesium Hydrides. Angewandte Chemie. 137(33). 4 indexed citations
5.
Zhao, Ziyin, Mingyang He, Ge Guan, et al.. (2024). Global research trends in the tumor microenvironment of hepatocellular carcinoma: insights based on bibliometric analysis. Frontiers in Immunology. 15. 1474869–1474869. 2 indexed citations
6.
Wang, Youpeng, Ziyin Zhao, Tingting Guo, et al.. (2024). SOCS5-RBMX stimulates SREBP1-mediated lipogenesis to promote metastasis in steatotic HCC with HBV-related cirrhosis. npj Precision Oncology. 8(1). 58–58. 2 indexed citations
7.
Li, Chen, et al.. (2024). Roles of Copper Transport Systems Members in Breast Cancer. Cancer Medicine. 13(24). e70498–e70498. 5 indexed citations
8.
Han, Bing, et al.. (2023). Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α in the Spotlight with Multiple Sclerosis. Neuroscience Bulletin. 40(2). 268–272. 1 indexed citations
9.
Wang, Youpeng, Mao Zhang, Haoran Li, et al.. (2022). SOCS5 knockdown suppresses metastasis of hepatocellular carcinoma by ameliorating HIF-1α-dependent mitochondrial damage. Cell Death and Disease. 13(11). 918–918. 6 indexed citations
10.
Sun, Chuandong, Bingyuan Zhang, Kai Ma, et al.. (2022). Establishment and Application of a Novel Difficulty Scoring System for da Vinci Robotic Pancreatoduodenectomy. Frontiers in Surgery. 9. 916014–916014. 3 indexed citations
11.
Liu, Qu, Zhiming Zhao, Xiuping Zhang, et al.. (2021). Perioperative and Oncological Outcomes of Robotic Versus Open Pancreaticoduodenectomy in Low-Risk Surgical Candidates. Annals of Surgery. 277(4). e864–e871. 48 indexed citations
12.
Mao, Yuqin, Shilong Zhang, Zhengyan Zhang, et al.. (2020). An approach using Caenorhabditis elegans screening novel targets to suppress tumour cell proliferation. Cell Proliferation. 53(6). e12832–e12832. 4 indexed citations
14.
Han, Bing, Jiaqi Zhang, Xiaomin Wang, et al.. (2019). <p>miR-449a Is Related to Short-Term Recurrence of Hepatocellular Carcinoma and Inhibits Migration and Invasion by Targeting Notch1</p>. OncoTargets and Therapy. Volume 12. 10975–10987. 12 indexed citations
15.
Zhang, Mao, Mei‐Sze Chua, Jie Hu, et al.. (2019). <p>High Inflammatory Factor Grading Predicts Poor Disease-Free Survival in AJCC Stage I-II Hepatocellular Carcinoma Patients After R0 Resection</p>. Cancer Management and Research. Volume 11. 10623–10632. 1 indexed citations
16.
Zhang, Mao, Shihai Liu, Mei‐Sze Chua, et al.. (2019). SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway. Cell Death and Disease. 10(8). 612–612. 102 indexed citations
17.
Xi, Yue, et al.. (2018). Clinical Practicality Study of the Difficulty Scoring Systems DSS-B and DSS-ER in Laparoscopic Liver Resection. Journal of Laparoendoscopic & Advanced Surgical Techniques. 29(1). 12–18. 6 indexed citations
18.
Wang, Yunliang, et al.. (2015). CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer Letters. 367(2). 122–128. 215 indexed citations
19.
Han, Bing. (2015). Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells. World Journal of Gastroenterology. 21(33). 9727–9727. 25 indexed citations
20.
Mura, Marco, Matthew Binnie, Bing Han, et al.. (2010). Functions of Type II Pneumocyte-Derived Vascular Endothelial Growth Factor in Alveolar Structure, Acute Inflammation, and Vascular Permeability. American Journal Of Pathology. 176(4). 1725–1734. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026